Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Silvia Vandeva"'
Autor:
Marek Bolanowski, Zaina Adnan, Mirjana Doknic, Mykola Guk, Václav Hána, Irena Ilovayskaya, Darko Kastelan, Tomaz Kocjan, Martin Kužma, Akmaral Nurbekova, Catalina Poiana, Nikolette Szücs, Silvia Vandeva, Roy Gomez, Sorin Paidac, Damien Simoneau, Ilan Shimon
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabo
Externí odkaz:
https://doaj.org/article/1bca364d9bca4016abd46e5ab897aea3
Autor:
Emil Natchev, Silvia Vandeva, Roussanka Kovatcheva, Georgi Kirilov, Krasimir Kalinov, Sabina Zacharieva
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 3, Pp 269-275 (2020)
ABSTRACT Objective Acromegaly is characterized by high neoplastic morbidity as a side effect of growth hormone (GH) hypersecretion. Increased incidence of goiter, thyroid carcinoma, and thyroid dysfunction is also reported. The aim of the present stu
Externí odkaz:
https://doaj.org/article/3f2d6e6b15f947afb7c9a4a3e684977f
Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
Autor:
Maria Kamusheva, Silvia Vandeva, Konstantin Mitov, Alexina Parvanova, Marina Pesheva, Nikolay Ganov, Yanitsa Rusenova, Lyubomir Marinov, Violeta Getova, Atanaska Elenkova, Guenka Petrova
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 438 (2023)
The purpose was to assess the level of medication adherence (MA) and related factors among individuals with acromegaly. The secondary goal was to assess the quality of life of patients and whether and how it correlates with the level of adherence. A
Externí odkaz:
https://doaj.org/article/31cf0d785dec40ac9a88ff0b8ae48187
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Background: Adherence to therapy is one of the most important elements during the therapeutic process ensuring the predefined therapeutic outcomes. The aim is to analyze the need and importance of treatment adherence guideline for acromegaly patients
Externí odkaz:
https://doaj.org/article/39d7f0315a954bfdbcb8d5a42fa66c42
Autor:
Maria Kamusheva, Yanitsa Rusenova, Silvia Vandeva, Atanaska Elenkova, Sabina Zaharieva, Miglena Doneva, Zornitsa Mitkova, Guenka Petrova
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 33, Iss 1, Pp 1560-1571 (2019)
Acromegaly is a rare disease with significant social and economic burden considering both main treatment patterns and concomitant diseases. The aim of this study was to present a systematic overview of the economic and pharmaco-economic studies of ac
Externí odkaz:
https://doaj.org/article/186ac849972b42a7932128816f44288a
Autor:
Maria Kamusheva, Silvia Vandeva, Konstantin Mitov, Yanitsa Rusenova, Atanaska Elenkova, Sabina Zacharieva, Zornitsa Mitkova, Konstantin Tachkov, Maria Dimitrova, Miglena Doneva, Dimitar Tcharaktchiev, Guenka Petrova
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
Background: Acromegaly and its comorbidities affect the patients' quality of life, each healthcare system and the society. This study aimed to evaluate clinical characteristics and treatment patterns and the economic burden of acromegaly.Materials an
Externí odkaz:
https://doaj.org/article/ced84081388b42749050489db6624920
Publikováno v:
F1000Research, Vol 3 (2014)
We describe a patient with a rare combination of acromegaly and primary aldosteronism. A 37 year-old female patient was diagnosed with acromegaly on the basis of typical clinical, hormonal and image characteristics. She presented also with one of the
Externí odkaz:
https://doaj.org/article/cf83223c16df44d9b293c0ab115a4cc4
Publikováno v:
Expert Opinion on Orphan Drugs. 10:48-54
Autor:
Marek Bolanowski, Zaina Adnan, Mirjana Doknic, Mykola Guk, Václav Hána, Irena Ilovayskaya, Darko Kastelan, Tomaz Kocjan, Martin Kužma, Akmaral Nurbekova, Catalina Poiana, Nikolette Szücs, Silvia Vandeva, Roy Gomez, Sorin Paidac, Damien Simoneau, Ilan Shimon
Publikováno v:
Frontiers in endocrinology. 13
Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabo
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Frontiers in Public Health
Frontiers in Public Health
Background: Adherence to therapy is one of the most important elements during the therapeutic process ensuring the predefined therapeutic outcomes. The aim is to analyze the need and importance of treatment adherence guideline for acromegaly patients